# US 2019/0167844 A1 · Biodegradable single-phase cohesive hydrogels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167844 A1
- Document ID: US20190167844A1
- Status: Published application
- Kind: A1
- Application number: 16/249,606
- Filed: 2019-01-16
- Published: 2019-06-06
- Earliest claimed: 2007-12-07
- Assignees: Laboratoires Vivacy
- Applicants: Laboratoires Vivacy
- Inventors: Estelle Marie PIRON; Guy VITALLY
- Web page: https://patentgrep.com/patent/US20190167844A1

## CPC

- A61L 27/26: Mixtures of macromolecular compounds
- A61K 8/042: {Gels}
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61K 8/733: {Alginic acid; Salts thereof}
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 8/736: {Chitin; Chitosan; Derivatives thereof}
- A61K 31/738: Cross-linked polysaccharides
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/58: Materials at least partially resorbable by the body
- A61P 13/02: of urine or of the urinary tract, e.g. urine acidifiers
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 27/02: Ophthalmic agents
- A61P 41/00: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/594: Mixtures of polymers
- A61K 2800/91: Injection
- A61L 2400/06: Flowable or injectable implant compositions
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A biodegradable single-phase cohesive hydrogel includes a homogenous mixture of 2 to 5 identical or different polymers interpenetrating each other in a single phase, wherein the polymers are independently crosslinked prior to interpenetration by mixing, and the crosslinked polymers are insoluble in water and miscible with each other.

## Claims

### Claim at position 1

1-24. (canceled)

### Claim 25

A biodegradable single-phase cohesive hydrogel, comprising:
a homogenous mixture of 2 to 5 identical or different polymers interpenetrating each other in a single phase, wherein:
the polymers are independently crosslinked prior to interpenetration by mixing; and
the crosslinked polymers are insoluble in water and miscible with each other.

### Claim 26 (depends on 25)

The hydrogel according to claim 25, wherein the polymers have different degrees of crosslinking.

### Claim 27 (depends on 25)

The hydrogel according to claim 25, wherein the polymers have identical degrees of crosslinking.

### Claim 28 (depends on 25)

The hydrogel according to claim 25, wherein each polymer is a polysaccharide.

### Claim 29 (depends on 28)

The hydrogel according to claim 28, wherein each polysaccharide is selected from the group consisting of hyaluronic acid, keratan, heparin, cellulose, cellulose derivatives, alginic acid, xanthan, carrageenan, chitosan, chondroitin, and biologically acceptable salts thereof.

### Claim 30 (depends on 28)

The hydrogel according to claim 28, wherein each polysaccharide is hyaluronic acid or a biologically acceptable salt thereof.

### Claim 31 (depends on 28)

The hydrogel according to claim 28, wherein at least one polysaccharide is selected from the group consisting of cellulose derivatives and biologically acceptable salts thereof.

### Claim 32 (depends on 28)

The hydrogel according to claim 28, wherein at least one polysaccharide is selected from the group consisting of chondroitin and biologically acceptable salts thereof.

### Claim 33 (depends on 28)

The hydrogel according to claim 28, wherein at least one polysaccharide is selected from the group consisting of chitosan and biologically acceptable salts thereof.

### Claim 34 (depends on 25)

The hydrogel according to claim 25, wherein the homogenous mixture is of 2 polymers.

### Claim 35 (depends on 25)

The hydrogel according to claim 25, further comprising one or more active principles selected from the group consisting of antioxidants, antiseptics, anti-inflammatories, local anesthetics, and mixtures thereof.

### Claim 36 (depends on 25)

The hydrogel according to claim 25, further comprising at least one antioxidant selected from the group consisting of mannitol and sorbitol.

### Claim 37 (depends on 25)

The hydrogel according to claim 25, further comprising a local anesthetic.

### Claim 38 (depends on 25)

A kit comprising the hydrogel according to claim 25 packaged in a sterile syringe.

### Claim 39

A process of preparing a biodegradable single-phase cohesive hydrogel, comprising:
independently crosslinking 2 to 5 polymers to obtain 2 to 5 identical or different crosslinked polymers; and
interpenetrating the crosslinked polymers by mixing to obtain a homogenous mixture of the crosslinked polymers in a single phase,
wherein the crosslinked polymers are insoluble in water and miscible with each other.

### Claim 40 (depends on 39)

The process according to claim 39, wherein crosslinking is performed using a bi- or polyfunctional crosslinking agent selected from the group consisting of bi- or polyfunctional epoxy compounds and divinyl sulfone.

### Claim 41 (depends on 39)

The process according to claim 39, wherein each polymer has a degree of crosslinking within a range from 0.02 to 0.4.

### Claim 42 (depends on 25)

A method of cosmetic injection comprising injecting the hydrogel according to claim 25 to fill a wrinkle, skin defect, or volume defect of a patient.
